EurekAlert! In the Spotlight

This month, we're turning our attention to Breast Cancer Awareness Month, a time dedicated to increasing awareness, supporting early detection, and highlighting the ongoing research shaping the future of breast cancer treatment and prevention.

Menopause drug Duavee may help prevent invasive breast cancer, clinical trial finds

Northwestern University
Reports and Proceedings

A drug already approved by the FDA to treat menopause symptoms may also help prevent invasive breast cancer, according to new findings from a multi-center phase 2 clinical trial led by Northwestern Medicine.

Meeting: 2025 ASCO Annual Meeting

28-May-2025

Damon Runyon Cancer Research Foundation awards Quantitative Biology Fellowships to five cutting-edge scientists

Damon Runyon Cancer Research Foundation
Grant and Award Announcement

Whether designing new proteins or mapping DNA structure, these scientists aim to shed light on these fundamental questions through large-scale data collection, mathematical modeling, and quantitative analysis.

28-May-2025

Women with low muscle mass have a worse prognosis in breast cancer treatment

Fundação de Amparo à Pesquisa do Estado de São Paulo
Peer-Reviewed Publication

The study conducted at the University of São Paulo evaluated data from 54 women who were newly diagnosed with early-stage disease. Accurately assessing a patient’s body composition is essential for monitoring metabolic changes related to breast cancer and identifying the need for earlier intervention, such as nutritional support and physical exercise.

Journal: Discover Oncology
Funder: Fundação de Amparo à Pesquisa do Estado de São Paulo

28-May-2025

Cutting-edge imaging breakthroughs for early breast cancer detection

Xia & He Publishing Inc.
Peer-Reviewed Publication

Breast cancer remains a leading cause of cancer-related mortality globally, underscoring the critical need for early detection to improve survival rates and reduce treatment invasiveness. This review synthesizes advancements in imaging technologies that enhance early diagnosis, focusing on their clinical applications, limitations, and future potential.

Journal: Cancer Screening and Prevention

28-May-2025

Mayo Clinic experts present key cancer research findings at ASCO

Mayo Clinic
Meeting Announcement

Mayo Clinic Comprehensive Cancer Center researchers will present their latest oncology findings at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. The event, recognized as one of the largest gatherings in the field of cancer research, will feature 59 Mayo Clinic-authored abstracts highlighting advancements in cancer care.

Meeting: 2025 ASCO Annual Meeting

26-May-2025

Dana-Farber researchers identify interventions for breast and colorectal cancer that could redefine standard of care

Dana-Farber Cancer Institute
Reports and Proceedings

Dana-Farber Cancer Institute researchers are leading four studies with compelling and potentially practice changing results in colorectal cancer and breast cancer.

Investigators will also present clinical trial results that support future research into new strategies for the treatment of rare and aggressive forms of cancer and new approaches to de-escalate treatment and improve quality of life.

Meeting: 2025 ASCO Annual Meeting

Welcome to In the Spotlight, where each month we shine a light on something exciting, timely, or simply fascinating from the world of science.

Latest News Releases

Menopause drug Duavee may help prevent invasive breast cancer, clinical trial finds

Damon Runyon Cancer Research Foundation awards Quantitative Biology Fellowships to five cutting-edge scientists

Women with low muscle mass have a worse prognosis in breast cancer treatment

Cutting-edge imaging breakthroughs for early breast cancer detection

Mayo Clinic experts present key cancer research findings at ASCO

Dana-Farber researchers identify interventions for breast and colorectal cancer that could redefine standard of care

City of Hope researchers to present cancer advances that could boost survival at the American Society of Clinical Oncology (ASCO) Annual Meeting